Targeting the heparan sulfate proteoglycan/heparanase axis as a novel therapeutic strategy to drive adipogenesis and block tumor growth of dedifferentiated liposarcoma.

Lanzi C et al.

NCBI PubMed Central · Papers · License: Open Access

machine learning systems

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 653359
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.